UNSPSC 85631902: Revision of nonautologous tissue substitute in left breast, open approach

This classification denotes the group of activities that yields a surgical intervention or procedure to revision of nonautologous tissue substitute in left breast, open approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0HWU0KZ

UNSPSC 85631902 Revision of nonautologous tissue substitute in left breast, open approach (Commodity) shows minimal alignment between its nominal clinical code and actual state and local procurement activity. The recent solicitations tagged to this code span occupational medical surveillance, disability medical evaluations, surgical benefit carve-outs, pharmacy benefit management, temporary health professional staffing, and youth detention medical services—none of which involve tissue substitutes or breast revision procedures. State and local buyers are acquiring comprehensive medical services programs, staffing, and administrative healthcare delivery functions rather than the specific surgical procedure the code nominally describes. The mix of issuing bodies reflects typical public-sector healthcare purchasing: county health systems, city retirement offices managing public safety pension boards, state transportation agencies, county human services departments, and county benefits administrations.

Recent activity spans Arizona (City of Phoenix Retirement Office, RFP for independent medical evaluation services, due October 16, 2026), California (City of Long Beach surgical benefit carve-out RFP, due October 7, 2026; County of Santa Clara Health System temporary staffing qualification pool, due October 7, 2026), Washington (Washington State Department of Transportation occupational medical surveillance, due October 9, 2026), and Texas and Florida (Harris County Juvenile Probation Department emergency medical services RFI, September 25, 2026; Collier County pharmacy benefit management, due April 9, 2026). The code's tagging appears to reflect administrative miscoding rather than substantive procurement scope; vendors targeting this commodity code will find little relevant opportunity signal and should verify with issuing bodies whether actual needs align with tissue-substitute supply or clinical services delivery.